Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Esophageal Cancer AJCC v7”

124 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 124 results

Early research (Phase 1)Ended earlyNCT00290719
What this trial is testing

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 6
Testing effectiveness (Phase 2)Study completedNCT00066716
What this trial is testing

Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Weill Medical College of Cornell University 39
Early research (Phase 1)Study completedNCT00537121
What this trial is testing

Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer

Who this might be right for
Esophageal CancerGastric CancerLiver Cancer
Roswell Park Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT00016900
What this trial is testing

PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00493025
What this trial is testing

Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Early research (Phase 1)Study completedNCT00238147
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Washington 18
Not applicableStudy completedNCT00898495
What this trial is testing

Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery

Who this might be right for
Esophageal Cancer
ECOG-ACRIN Cancer Research Group 118
Not applicableActive Not RecruitingNCT01035398
What this trial is testing

Genetic and Environmental Risk Factors Related to Esophageal Cancer

Who this might be right for
Esophageal Cancer
Massachusetts General Hospital
Large-scale testing (Phase 3)Study completedNCT00052910
What this trial is testing

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 546
Testing effectiveness (Phase 2)Study completedNCT00045526
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionRecurrent Esophageal Cancer+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Ended earlyNCT00006472
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer

Who this might be right for
Esophageal Cancer
Medstar Health Research Institute 4
Not applicableStudy completedNCT00629863
What this trial is testing

Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
North Wales Organisation for Randomised Trials in Health 700
Testing effectiveness (Phase 2)Study completedNCT00003087
What this trial is testing

Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 25
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00003192
What this trial is testing

Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
University of Chicago 15
Large-scale testing (Phase 3)Study completedNCT00002897
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
European Institute of Oncology 240
Early research (Phase 1)Study completedNCT00601692
What this trial is testing

Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 27
Large-scale testing (Phase 3)Study completedNCT00002631
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 298
Testing effectiveness (Phase 2)Study completedNCT00030862
What this trial is testing

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00063986
What this trial is testing

Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer

Who this might be right for
Esophageal Cancer
Eastern Cooperative Oncology Group 110
Load More Results